Log in
FREE 15-Day Trial
Intelligent Investor
Intelligent Investor
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. Oncosil Medical Limited (OSL)
  6. Company Announcements

Oncosil Medical Limited (ASX: OSL) - Announcements

Current share price for OSL : $0.004 0.001 (20%)

ASX company news and announcements for Oncosil Medical Limited (OSL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Oncosil Medical Limited (OSL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Oncosil Medical Limited (OSL), please use our Company Announcements tool to search across all ASX-listed companies.

Intelligent Investor free trial for buy hold sell stock recommendations

Latest company announcements for Oncosil Medical Limited (OSL)

Search all Announcements
Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg		 Gain/Loss
$12 Notification regarding unquoted securities - OSL 3 May 2024 5:11PM $0.005 $0.004 $0.004 fallen by 20%
$12 Application for quotation of securities - OSL 3 May 2024 5:10PM $0.005 $0.004 $0.004 fallen by 20%
$12 Notification regarding unquoted securities - OSL 2 May 2024 10:57AM $0.005 $0.004 $0.004 fallen by 20%
$12 Application for quotation of securities - OSL 2 May 2024 10:52AM $0.005 $0.004 $0.004 fallen by 20%
$12 $5.3 million raised under Entitlement Offer 2 May 2024 10:48AM $0.005 $0.004 $0.004 fallen by 20%
$12 1st Study in Man Increases Pancreatic Tumor Vascularity 1 May 2024 8:28AM $0.005 $0.004 $0.004 fallen by 20%
$12 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2024 3:52PM $0.005 $0.004 $0.004 fallen by 20%
$12 Two more PANCOSIL Trial treatments using OncoSil device 17 Apr 2024 5:07PM $0.007 $0.004 $0.004 fallen by 42.86%
$12 First patient treated with OncoSil device in Turkiye 16 Apr 2024 8:58AM $0.007 $0.004 $0.004 fallen by 42.86%
$12 Notice of Extraordinary General Meeting/Proxy Form 16 Apr 2024 8:47AM $0.007 $0.004 $0.004 fallen by 42.86%
$12 First patient treated in the UK for the TRIPP-FXX study 12 Apr 2024 8:26AM $0.006 $0.004 $0.004 fallen by 33.33%
$12 UK Private Insurer Approves Reimbursement for OncoSil 9 Apr 2024 9:34AM $0.006 $0.004 $0.004 fallen by 33.33%
$12 First Austria-based treatments utilising the OncoSil device 5 Apr 2024 8:38AM $0.005 $0.004 $0.004 fallen by 20%
$12 Dispatch of Entitlement Offer Prospectus 4 Apr 2024 9:35AM $0.005 $0.004 $0.004 fallen by 20%
$12 Notice under section 708A 28 Mar 2024 4:12PM $0.005 $0.004 $0.004 fallen by 20%
$12 Application for quotation of securities - OSL 28 Mar 2024 4:02PM $0.005 $0.004 $0.004 fallen by 20%
$12 Prospectus - Entitlement Offer 25 Mar 2024 8:54AM $0.006 $0.004 $0.004 fallen by 33.33%
$12 Update - Proposed issue of securities - OSL 22 Mar 2024 2:50PM $0.007 $0.004 $0.004 fallen by 42.86%
$12 Placement and Entitlement Offer - amended timetable 22 Mar 2024 2:32PM $0.007 $0.004 $0.004 fallen by 42.86%
$12 Update - Proposed issue of securities - OSL 22 Mar 2024 8:20AM $0.007 $0.004 $0.004 fallen by 42.86%
$12 Placement and Entitlement Offer - addendum 21 Mar 2024 9:32AM $0.007 $0.004 $0.004 fallen by 42.86%
$12 Investor Presentation 20 Mar 2024 10:28AM $0.008 $0.004 $0.004 fallen by 50%
$12 Proposed issue of securities - OSL 20 Mar 2024 10:20AM $0.008 $0.004 $0.004 fallen by 50%
$12 Proposed issue of securities - OSL 20 Mar 2024 10:20AM $0.008 $0.004 $0.004 fallen by 50%
$12 Proposed issue of securities - OSL 20 Mar 2024 10:20AM $0.008 $0.004 $0.004 fallen by 50%

1 - 25 of 531 results

Page 1 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.